Biohub, the U.S. Department of Energy and the National Institutes of Health announced on 7 October 2026 a major expansion of the Virtual Biology Initiative, an effort to generate open data for AI models that predict how cells behave. The release says the organisations together are investing $1.8 billion in funding, data, computation and new measurement technology.
Google DeepMind, Isomorphic Labs and Meta are collectively investing $300 million in the initiative, the release says. It calls the total the largest coordinated commitment to generating AI-ready biological data to date.
Business Pill · WHEN DATA IMPROVES THE NEXT MODEL
A one-minute explainer of the data flywheel: when using a system produces data that makes the system better, each turn of the loop improves the next. It teaches the general idea only and says nothing about any company in this story.
The key insight: As we read it, the emphasis is on data. The release describes the $1.8 billion as funding, data, computation and measurement technology to build open datasets that others can train cell models on, with two AI labs and Meta among the funders. As we read it, the bet is that the bottleneck for AI in biology is measurement, and that the data should be shared.
The release lists several commitments. It says DOE will invest more than $500 million over five years in lab measurement, modeling and computation, through the Genesis Mission it leads. It says NIH will coordinate datasets, repositories and knowledge bases developed through more than $500 million in prior federal investment, which Biohub will help standardize for AI model training.
Biohub’s founding $500 million commitment, announced in April 2026, anchors the work: $400 million for new measurement technology such as cryo-electron tomography and large-scale microscopy, and $100 million for research outside Biohub. The three companies add $300 million combined.
On our reading of the release, the NIH share is existing data from earlier federal spending rather than new cash, so the new money in the total is smaller than $1.8 billion.
The commitments named in the release of 7 October 2026, which sum to about $1.8 billion on our arithmetic (the release does not itemise its total): Biohub’s founding $500 million; DOE more than $500 million over five years; NIH datasets and resources developed through more than $500 million of prior federal investment, which is existing data rather than new cash in our reading; and $300 million combined from Google DeepMind, Isomorphic Labs and Meta.
What They Want to Build
The release says the datasets will let researchers build and use AI models that ask, predict and answer biological questions digitally, expanding cell response data to interventions across far more cell types and conditions than have been studied.
“An accurate predictive model of biology could dramatically accelerate scientific discovery by enabling scientists to perform experiments digitally,” said Biohub Head of Science Alex Rives. The release describes the result as an open resource for the research community.
It names the Allen Institute, Broad Institute, Gladstone Institutes, the Human Cell Atlas, the Human Protein Atlas and the Wellcome Sanger Institute as groups working with the initiative, says NVIDIA will support it with computing infrastructure and expertise, and says Renaissance Philanthropy is helping to expand funding.
The Structural Read
On our reading, the commitments the release lists sum to about $1.8 billion, though the release does not itemise its total. In that reading, DOE’s more than $500 million over five years and the companies’ $300 million are new commitments, Biohub’s $500 million is its founding commitment from April, and NIH’s share is datasets built with more than $500 million of earlier federal money.
Most of Biohub’s own money goes to instruments. The release says $400 million of its founding commitment supports new measurement technology, including cryo-electron tomography and microscopy that can image millions to billions of cells.
The release gives no data-access terms. It describes an open resource, but in what we read it does not say what Google DeepMind, Isomorphic Labs or Meta get for their $300 million, or when data is released.
Alex Rives, Head of Science, Biohub
“An accurate predictive model of biology could dramatically accelerate scientific discovery by enabling scientists to perform experiments digitally.”
Three Implications
AN OPEN DATA RESOURCE The release frames the $1.8 billion as funding, data, computation and measurement technology for AI-ready open datasets.
ON OUR READING, NOT ALL OF IT IS NEW MONEY On our reading, NIH’s share is existing data built with more than $500 million of prior federal investment.
THE RELEASE SETS NO CORPORATE TERMS The release does not split the $300 million among the three companies or set out their access to the data.
The framework’s starting point: “Close the SCARCE layer (keep proprietary) + Open the ABUNDANT layer (commoditize)”
The Virtual Biology Initiative puts its funders’ money into data it describes as open. As we read it, the open question is which layer the corporate funders treat as scarce: the release does not set out what Google DeepMind, Isomorphic Labs or Meta keep for their $300 million.
What Is Not Established
We read the release in full. In the release we read, there is no split of the $300 million between Google DeepMind, Isomorphic Labs and Meta, and no terms for how the companies may use the data or when it becomes public. We did not read other coverage of the announcement, and we did not contact Biohub or the partners.
The DOE and NIH figures are stated as “more than” $500 million each, and the DOE money is spread over five years.
Business Engineer Framework
The Map of AI — Where Applied AI Sits
The Map of AI places more than 200 companies across nine layers of the stack, from silicon to application. It shows where scientific AI efforts sit relative to the model labs and compute providers behind them.
Biohub, DOE and NIH say the Virtual Biology Initiative now totals $1.8 billion in funding, data, computation and technology, including $300 million from Google DeepMind, Isomorphic Labs and Meta, to produce open data for AI models of the cell. On our reading, part of the total is NIH data from earlier federal spending.
A note on sourcing. We read the release of 7 October 2026 from Biohub, DOE and NIH in full, as published on PR Newswire. All figures are theirs; the reading that NIH’s share is existing data is ours. We did not use other coverage and did not contact Biohub or its partners. Nothing here is a forecast, and nothing here is financial or investment advice.
Gennaro Cuofano is a CRO and tech executive who has worked in AI since late 2015, starting with bringing NLP, natural-language generation, voice and chatbot products to the marketing industry. His background is in law and finance: he holds a Master's degree in Law and an International MBA with an emphasis on corporate finance (LUISS Business School and the University of San Diego, 2012), and worked as a financial analyst at a real-estate investment firm in San Diego and as an assistant controller. His work focuses on business model strategy, business engineering and, more broadly, structural analysis: how companies make money, read from their own filings. He created FourWeekMBA and leads research there and at The Business Engineer, his newsletter on AI and business strategy, with over 95,000 subscribers and more than 1,000 published analyses. His writing has also appeared on Entrepreneur (for example, How to Digitize a Family Business in Europe) and HackerNoon. Find him on LinkedIn and Substack. See how we source.
